For most healthy adults, a continuous glucose monitor is not medically necessary, but it can offer a useful window into how food, sleep, stress, and exercise affect blood sugar in real time. Whether it is worth the cost depends on what you want to learn and how you plan to use the data.
Continuous glucose monitors were built for people with diabetes who need to track blood sugar closely to manage insulin and avoid dangerous highs and lows. Over the past few years, a growing number of companies have marketed the same core technology, a small sensor worn on the arm or abdomen that reads glucose every few minutes, to people with no diabetes diagnosis at all. The pitch: see your own metabolic response to specific foods, workouts, and sleep in a way a once-a-year blood test never could.
But does that data mean much for someone whose blood sugar already falls within a normal range? The honest answer is: sometimes, and less than the marketing implies. Here is what the research does and does not support.
What the Research Actually Says
A continuous glucose monitor (CGM) measures glucose in the interstitial fluid just under the skin, not blood glucose directly, and reports a reading every few minutes. In people with diabetes, this data is used clinically to fine-tune insulin dosing and catch dangerous lows or highs between doctor visits, a use case with decades of research behind it.
The use case for non-diabetic, metabolically healthy adults is much newer, and the evidence base is considerably thinner. One widely cited Stanford study that fitted non-diabetic adults with CGMs found meaningful glucose variability even among participants whose fasting glucose and A1c results were within a normal range, with some spending stretches of time in glucose ranges more typically associated with prediabetes. That finding is often used to argue standard lab tests miss something CGMs can catch. It is a genuinely interesting result, but it is a single study of a modest sample, not a settled conclusion.
What the research does not yet show is that CGM use, on its own, improves health outcomes in people without diabetes or prediabetes. Most of the outcome data — weight loss, improved insulin sensitivity, reduced cardiometabolic risk — comes from studies of people who already have diabetes or prediabetes, where tighter glucose control has clear clinical stakes. For healthy users, CGM companies largely rely on the idea that behavior change follows from seeing a glucose curve. That is a reasonable hypothesis, but it has not been rigorously tested in large trials of non-diabetic populations, so treat claims that CGM use itself drives long-term metabolic improvement as unproven rather than established.
Glucose variability is also normal physiology, not a warning sign by default. Blood sugar naturally rises after eating, especially after carbohydrate-heavy meals, and shifts in response to stress, poor sleep, illness, caffeine, and hormonal cycling. A single post-meal spike on a CGM graph is not, by itself, evidence of a metabolic problem.
How to Think About Using a CGM as a Healthy Person
What you might realistically learn
The most defensible use of a CGM for a non-diabetic person is pattern recognition, not diagnosis. Wearing one for a couple of weeks can show which specific meals or habits tend to produce larger glucose swings for your body specifically, since individual responses to the same food vary between people. It can also surface indirect patterns, like poor sleep correlating with more volatile readings, that are easy to miss without continuous data.
Normal variability is not automatically alarming
Because CGMs show data continuously rather than as a single snapshot, they can make ordinary glucose fluctuation look more dramatic than it is. A rise after a carb-heavy meal that returns to baseline within a couple of hours is generally expected physiology, not evidence of dysfunction. Reading every fluctuation as a problem to fix is a common way healthy users misuse this data, and it can create food anxiety that outweighs any benefit.
Data quality has limits
Interstitial glucose readings lag blood glucose by several minutes, and accuracy in the normal, non-diabetic range has been studied less extensively than accuracy in diabetic ranges. Sensor placement and hydration can also introduce noise. Treat CGM data as a useful trend indicator, not a lab-grade diagnostic result.
Common Misconceptions About CGM Data
1. A glucose spike means something is wrong
Post-meal glucose rises are normal and expected, particularly after carbohydrate-dense meals. What matters more than the presence of a spike is how high it goes and how quickly it returns to baseline, and even those figures should be interpreted cautiously without clinical context.
2. Lower average glucose is always better
Glucose exists to fuel the body, including the brain and working muscle. Chasing an artificially flat, low glucose curve is not a validated wellness goal, and it is not something the emerging research supports as a target to optimize toward.
3. CGM readings are as precise as a lab blood draw
CGMs measure a different fluid compartment than a venous blood draw. They are useful for trends, less so for precise single-point values.
4. If it helps people with diabetes, it will help healthy people the same way
The clinical case for CGM use in diabetes management is well established because tighter glucose control changes real medical outcomes for that population. That does not automatically transfer to non-diabetic users, where outcome evidence is still emerging and much thinner.
5. You need a doctor’s prescription to try one
Some CGMs marketed to non-diabetic users, including certain Dexcom and Abbott models, are now available over the counter in the United States without a prescription, following recent FDA clearances for OTC glucose biosensors. Requirements vary by product, so check the specific brand.
When This May or May Not Be Right for You
Might reasonably consider it
- Athletes fine-tuning fueling: Endurance athletes experimenting with carbohydrate timing around training may find glucose trend data useful for adjusting pre- and post-workout nutrition.
- People making a significant dietary change: Anyone shifting eating patterns (lower-carb, intermittent fasting, or otherwise) may find a short CGM trial useful as a feedback loop, understanding it is one data point, not a verdict on the diet’s overall value.
- People with risk factors, working with a clinician: Someone with a family history of type 2 diabetes may reasonably use a CGM as one input into a broader conversation with a provider, not as a replacement for standard screening.
Probably does not need one
- Generally healthy adults with no risk factors: Without a specific question to answer, ongoing CGM use is unlikely to add much beyond a reasonably balanced diet and normal activity.
- Anyone prone to food anxiety: Continuous data can amplify anxious relationships with eating, since normal variability can look alarming without context.
- Anyone expecting a diagnosis from the data: A CGM trend line is not a diagnostic tool.
An important caution
If you have a personal or family history of diabetes or prediabetes, do not use CGM data to self-diagnose or self-manage. Bring readings to a doctor and let standard, validated tests (fasting glucose, A1c, oral glucose tolerance testing) guide any actual diagnosis. A CGM can start that conversation, but it is not a substitute for it.
Tools and Services That Help
If a short trial makes sense for your situation, several services package CGM sensors with an app and coaching layer aimed at non-diabetic users. Nutrisense pairs a CGM with dietitian support and an app that logs meals alongside glucose trends. Levels Health focuses on metabolic-health tracking with its own app layered over a standard CGM sensor, and typically requires an application to join. Signos markets its program around weight-management goals paired with glucose data. Dexcom Stelo is Dexcom’s over-the-counter biosensor built for non-diabetic and non-insulin users, sold without the prescription requirement of Dexcom’s diabetes-focused devices. Pricing generally runs $50-$100 or more per month depending on sensor frequency and coaching tier (prices as of 2026). Abbott’s Lingo is another OTC option, an FDA-cleared biosensor marketed toward general metabolic tracking.
Glucose data tends to be more useful when read alongside other signals like sleep and activity rather than in isolation. Our comparison of the best fitness trackers and smartwatches covers devices with strong sleep and activity tracking, and our Oura Ring vs. Whoop vs. Garmin breakdown can help you decide which wearable pairs best with a CGM trial for a fuller picture of how sleep, stress, and activity line up with glucose trends.
Frequently Asked Questions
Can a healthy person benefit from wearing a CGM?
Some people find it useful for identifying which foods or habits produce larger personal glucose responses, particularly when making a specific dietary change. Strong evidence that CGM use alone improves long-term health outcomes in non-diabetic users is still limited.
Is a prescription required to buy a CGM?
It depends on the product. Some devices marketed to non-diabetic users, including Dexcom Stelo and Abbott Lingo, are available over the counter in the United States following recent FDA clearances. Other CGM-based programs may still require a clinician’s involvement, so check the specific brand.
Does a glucose spike after a meal mean I have a problem?
Not necessarily. Post-meal glucose rises are normal, especially after carbohydrate-heavy meals, and typically return to baseline within a couple of hours in people without diabetes. How high, how long, and how often matters more than the presence of a single spike.
How long should I wear a CGM to get useful information?
Many non-diabetic CGM programs are built around two- to four-week sensor cycles, generally enough time to spot patterns across a range of meals, workouts, and typical week-to-week variation. Ongoing, indefinite use has not been shown to add proportional benefit for most healthy users.
Should a CGM replace regular blood work?
No. A CGM shows short-term glucose trends but is not a substitute for standard diagnostic tests like fasting glucose or A1c. If you have risk factors or concerns, talk to a healthcare provider rather than interpreting CGM trends on your own.
Bottom Line
A continuous glucose monitor can give a healthy adult a more detailed, personalized view of how specific foods, workouts, sleep, and stress affect blood sugar than a once-a-year lab test ever could. That is a genuinely useful feedback loop for some people, particularly athletes fine-tuning fueling or anyone in the middle of a significant dietary change. What it is not, based on the research available today, is a proven tool for improving metabolic health outcomes on its own; normal glucose variability on the graph is not automatically a red flag.
If you have a personal or family history of diabetes or prediabetes, treat CGM data as a conversation to have with a doctor rather than something to interpret alone. For everyone else, a short, purposeful trial with a clear question in mind beats open-ended, indefinite tracking.